Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-RAD LABORATORIES, INC. Director's Dealing 2020

Apr 30, 2020

30786_dirs_2020-04-30_8d757ebe-b1e0-40bd-af94-7bbe4639533f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-RAD LABORATORIES, INC. (BIO,BIOB)
CIK: 0000012208
Period of Report: 2020-04-29

Reporting Person: Last Andrew J. (EVP, Chief Operating Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-04-29 Bio-Rad A Common Stock M 1000 Acquired 1025.9765 Direct
2020-04-29 Bio-Rad A Common Stock F 346 $436.27 Disposed 679.9765 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-04-29 Restricted Stock Units $0 M 1000 Disposed Bio-Rad A Common Stock (1000) Direct

Footnotes

F1: Shares of Class A common stock acquired on the vesting of restricted stock units.

F2: Includes 25.9765 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 3/31/2020.

F3: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.

F4: The restricted stock units vest in five equal annual installments beginning on April 29, 2020.